Elixir Pharmaceuticals Inc. entered a licensing deal with Bristol-Myers Squibb Co. to develop and sell the latter's preclinical growth hormone secretagogue, BMS-604992, and five related compounds. "We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results